Home/AI Tools/NeuroX1

NeuroX1

AI mental health diagnostic platform.
General Information
Founders:
Conner Myers, Lucas Myers, Maxwell Dordevic
Founded Date:
2021-11-18
Total Funding Amount:
1970000
Headquarters Region:
Southern US
Domain Rating:
9
Organic Traffic:
33
Last Equity Funding Amount:
220000
Last Equity Funding Date:
2024-03-15
Last Equity Funding Type:
Seed

Overview

NeuroX1 is an AI-powered platform designed to facilitate mental health diagnostics and therapy for clinicians and practitioners.

Key Features

AI diagnostic tool, therapy planning, patient management, real-time analytics.

Pros

Enhances diagnostic accuracy, improves therapy outcomes, user-friendly interface for practitioners.

Cons

Requires a learning curve for new users, dependence on data accuracy.

bg

Get Exclusive Content
Straight to Your Inbox

Subscribe to our [A] Growth Newsletter

More AI tools like this